Browse studies

Find your next paid study

6 recruiting studies matching your filters

A Phase III Randomised, Parallel-Group, Double-Blind, Placebo-Controlled, Two-Arm Study to Evaluate the Efficacy and Safety of Elafibranor 80 mg on Long-Term Clinical Outcomes in Adult Participants With Primary Biliary Cholangitis (PBC)

The participants of this study will have confirmed Primary Biliary Cholangitis (PBC) and cirrhosis (scarring of the liver). PBC is a slowly progressive diseas…

Primary Biliary Cholangitis (PBC)

Estimated

~$50 – $2,250

Actual pay is set by the research site.

IpsenNCT06016842

Phase 3

A Phase 3b/4, Multicenter, Parallel-Group, Double-Blind, Placebo Controlled, Two-Arm, Long-Term Study to Evaluate the Safety and Efficacy of Saroglitazar Magnesium on Clinical Outcomes in Participants With Primary Biliary Cholangitis (PBC)

Long-Term Study to Evaluate the Safety and Efficacy in Participants with Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes (EPICS-V)

Primary Biliary Cholangitis

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Zydus Therapeutics Inc.NCT07216235

Phase 3

AFFIRM: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

The goal of this clinical study is to learn more about the study drug, seladelpar, and its effects on clinical outcomes in participants with primary biliary ch…

Primary Biliary Cholangitis

Estimated

~$50 – $2,250

Actual pay is set by the research site.

Gilead SciencesNCT06051617

Characterizing Fatigue, Sleep and Activity in Patients Living With Primary Biliary Cholangitis (PBC) Using Digital Health Technology

The purpose of this study is to explore the use of digital health technology for measuring symptoms and daily health in people with primary biliary cholangitis…

Primary Biliary Cholangitis (PBC)

Estimated

~$10 – $750

Actual pay is set by the research site.

Stanford UniversityNCT07631442

Phase 2

Nemolizumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus: An Open-Label, Single-Arm, Exploratory Study

The purpose of this research is to investigate the efficacy of nemolizumab in the treatment of adults with moderate to severe chronic hepatic pruritus.

Chronic Hepatic PruritusCholestatic Liver DiseasePrimary Biliary Cholangitis+2 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Mayo ClinicNCT07843420

Phase 3

A Double-blind, Placebo-controlled, Randomized, Phase 3 Study to Evaluate the Efficacy and Safety of Saroglitazar Magnesium on Normalization of Alkaline Phosphatase Levels in Patients With Primary Biliary Cholangitis and an Incomplete Response or Intolerance to Ursodeoxycholic Acid

Study of Saroglitazar Magnesium for PBC Patients with Incomplete Response or Intolerant to UDCA Therapy

Primary Biliary Cholangitis

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Zydus Therapeutics Inc.NCT07424677